RMC
JAZZ icon

Resources Management Corp’s Jazz Pharmaceuticals JAZZ Stock Holding History

Resources Management Corp’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$12K Hold
100
– – ﹤0.01% 382
2018
Q3 		$16K Buy
+100
New +$17.2K ﹤0.01% 354

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Resources Management Corp's JAZZ Position: Q4 2018 in Review

Resources Management Corp held its Jazz Pharmaceuticals (JAZZ) position steady in Q4 2018 at 100 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #382.

Resources Management Corp first reported a position in JAZZ in Q3 2018 and has held it in 2 quarters since. The position peaked at $16K in Q3 2018. 417 funds tracked by Wall St. Rank hold JAZZ as of Q4 2018.

  • Resources Management Corp held 100 shares of Jazz Pharmaceuticals worth $12K as of Q4 2018.
  • Resources Management Corp left its Jazz Pharmaceuticals share count unchanged in Q4 2018.
  • Jazz Pharmaceuticals made up ﹤0.01% of Resources Management Corp's portfolio in Q4 2018, its #382 holding.
  • Resources Management Corp first reported a position in Jazz Pharmaceuticals in Q3 2018 and has held it in 2 quarters since.
  • Resources Management Corp's Jazz Pharmaceuticals position peaked at $16K in Q3 2018.
  • 417 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2018.

Based on Resources Management Corp's 13F filing for Q4 2018, filed 21 Feb 2019.